Abstract:OBJECTIVE:To discuss the methods and effects of a series of surgery oriented therapies in the treatment of large primary liver cancers.METHODS:From January 1993 to June 1999, 191 patients with large liver cancer were treated chiefly by operation. The size of the primary cancer varied from 5.2 to 19.7 cm (median 9.4 cm). Various kinds of liver resections were performed in 121 patients and, as a supplement, deep cryosurgery was carried for out the rest 70 patients. Importable drug delivery system (IDDS) was instituted intraoperatively. Transcatheter arterial chemo-embolization (TACE, THP 30-60 mg, E-ADM 20-40 mg, CDDP 40-80 mg, MMC 10-20 mg, iodine oil 5-30 ml), percutaneous ethanol injection (PEI), bioimmunotherapy and the traditional Chinese medicine were used pre- and post-operatively. CT angiography (CTA) and CT during arterial portography (CTAP) were used to find satellite nodules. Early recurrence was diagnosed by AFPmRNA monitor in peripheral blood. Child's classification plus branch chain amino acid/aromatic amino acid (BCAA/AAA) were adopted in evaluating the pre-operative liver functions.RESULTS:Remarkable results were observed after this surgery oriented serial treatment. The 1-, 3- and 5-year survival rates in the resection group were 75.8%, 45.6% and 30.4%, respectively. The 1- and 3-year survival rates in the cryosurgery group were 63.2% and 37.0%. The operative mortality was 1.6%. Recurrence rates were 69.2% in AFPmRNA positive group and 33.3% in AFPmRNA negative group. Comparing this two groups, significant difference was observed (P < 0.05). BCAA/AAA were lower than 1.5 in two patients died after resection.CONCLUSION:A serial treatment with surgery as the chief modality gives satisfactory results in large primary liver cancers. This regimen should be adhered to as a main strategy in dealing with large liver cancers. AFPmRNA in the peripheral blood, signifying a recurrence, may become a hope of a new clinical parameter. BCAA/AAA plus Child's classification is able to evaluate more accurately the hepatic functional reserve before surgery.

Surgical Treatment for Giant Primary Liver Cancer:A Report of 146 Cases

Retrospective Analysis on 682 Cases of Liver Cancer after Surgical Treatment

Surgical Treatment of Primary Liver Cancer: Report of 5524 Patients

Results of Hepatectomy for Huge Primary Liver Cancer

A Surgery Oriented Serial Treatments of 191 Patients with Large Primary Liver Cancer

[Surgical Treatment for the Giant Hepatic Carcinomas Occupying the Central Part of the Liver].

Surgical Treatment for Primary Liver Cancer

Hepatectomy in the Treatment of Very Big Primary Liver Cancer: Report of 86 Cases.

Surgical Treatments of Primary Liver Cancer Patients with Severe Cirrhosis: a Report of 78 Cases CHEN

Huge pedunculated hepatocellular carcinoma and its surgical treatment

Surgical Treatment for Primary Liver Cancer with Portal Vein Tumor Thrombus(13 Cases Report)

Hepatectomy Treating Primary Liver Cancer: 300 Cases Report

Serial Therapies Oriented by Surgery for Large Primary Liver Carcinoma.

Surgical treatment to the hemorrhage of spontaneous rupture of hepatocellular carcinoma: an analysis of 15 cases

Resection of huge liver cancer involving the second porta hepatis: A report of 55 cases

Hepatectomy for 894 patients with huge primary liver carcinoma

Analysis of Surgery for Multiple Primary Cancers in Liver and Gastrium: a Report of 14 Cases

Selective Ligation of Portal Vein and Hepatic Vein Combined with Sequential Hepatectomy for the Treatment of Giant Liver Cancer

Liver Resection for Huge Tumors in Heaptic Caudate Lobe

Anatomical Trisectionectomy Using Anterior Approach and Hanging Maneuver for the Treatment of Giant Liver Cancer

Surgery for large primary liver cancer more than 10 cm in diameter